Study the mRNA level of IL-27/IL-27R pathway molecules in kidney transplant rejection

Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role...

Full description

Saved in:
Bibliographic Details
Published inArchivio italiano di urologia, andrologia Vol. 95; no. 4; p. 11691
Main Authors Karimi, Aftab, Yaghobi, Ramin, Roozbeh, Jamshid, Rahimi, Zahra, Afshari, Afsoon, Akbarpoor, Zahra, Heidari, Mojdeh
Format Journal Article
LanguageEnglish
Published Italy PAGEPress Publications 29.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role in managing immune responses aimed at countering rejection. Consequently, this investigation endeavors to explore the precise function of IL-27 and its associated cytokines in the context of kidney transplant rejection. The study involved the acquisition of blood samples from a cohort of participants, consisting of 61 individuals who had undergone kidney transplantation (comprising 32 nonrejected patients and 29 rejected patients), and 33 healthy controls. The expression levels of specific genes were examined using SYBR Green Real-time PCR. Additionally, the evaluation encompassed the estimation of the ROC curve, the assessment of the relationship between certain blood factors, and the construction of protein-protein interaction networks for the genes under investigation. Significant statistical differences in gene expression levels were observed between the rejected group and healthy controls, encompassing all the genes examined, except for TLR3 and TLR4 genes. Moreover, the analysis of the Area Under the Curve (AUC) revealed that IL-27, IL-27R, TNF-α, and TLR4 exhibited greater significance in discriminating between the two patient groups. These findings highlight the potential importance of IL-27, IL-27R, TNF-α, and TLR4 as key factors for distinguishing between individuals in the rejected group and those in the healthy control group. In the context of kidney rejections occurring within the specific timeframe of 2 weeks to 2 months post-transplantation, it is crucial to emphasize the significance of cytokines mRNA level, including IL-27, IL-27R, TNF-α, and TLR4, in elucidating and discerning the diverse immune system responses. The comprehensive examination of these cytokines' mRNA level assumes considerable importance in understanding the intricate mechanisms underlying kidney rejection processes during this critical period.
AbstractList Background: Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role in managing immune responses aimed at countering rejection. Consequently, this investigation endeavors to explore the precise function of IL-27 and its associated cytokines in the context of kidney transplant rejection. Methods: The study involved the acquisition of blood samples from a cohort of participants, consisting of 61 individuals who had undergone kidney transplantation (comprising 32 nonrejected patients and 29 rejected patients), and 33 healthy controls. The expression levels of specific genes were examined using SYBR Green Real-time PCR. Additionally, the evaluation encompassed the estimation of the ROC curve, the assessment of the relationship between certain blood factors, and the construction of protein-protein interaction networks for the genes under investigation. Results: Significant statistical differences in gene expression levels were observed between the rejected group and healthy controls, encompassing all the genes examined, except for TLR3 and TLR4 genes. Moreover, the analysis of the Area Under the Curve (AUC) revealed that IL-27, IL-27R, TNF-α, and TLR4 exhibited greater significance in discriminating between the two patient groups. These findings highlight the potential importance of IL-27, IL-27R, TNF-α, and TLR4 as key factors for distinguishing between individuals in the rejected group and those in the healthy control group. Conclusions: In the context of kidney rejections occurring within the specific timeframe of 2 weeks to 2 months post-transplantation, it is crucial to emphasize the significance of cytokines mRNA level, including IL-27, IL-27R, TNF-α, and TLR4, in elucidating and discerning the diverse immune system responses. The comprehensive examination of these cytokines’ mRNA level assumes considerable importance in understanding the intricate mechanisms underlying kidney rejection processes during this critical period.
Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role in managing immune responses aimed at countering rejection. Consequently, this investigation endeavors to explore the precise function of IL-27 and its associated cytokines in the context of kidney transplant rejection. The study involved the acquisition of blood samples from a cohort of participants, consisting of 61 individuals who had undergone kidney transplantation (comprising 32 nonrejected patients and 29 rejected patients), and 33 healthy controls. The expression levels of specific genes were examined using SYBR Green Real-time PCR. Additionally, the evaluation encompassed the estimation of the ROC curve, the assessment of the relationship between certain blood factors, and the construction of protein-protein interaction networks for the genes under investigation. Significant statistical differences in gene expression levels were observed between the rejected group and healthy controls, encompassing all the genes examined, except for TLR3 and TLR4 genes. Moreover, the analysis of the Area Under the Curve (AUC) revealed that IL-27, IL-27R, TNF-α, and TLR4 exhibited greater significance in discriminating between the two patient groups. These findings highlight the potential importance of IL-27, IL-27R, TNF-α, and TLR4 as key factors for distinguishing between individuals in the rejected group and those in the healthy control group. In the context of kidney rejections occurring within the specific timeframe of 2 weeks to 2 months post-transplantation, it is crucial to emphasize the significance of cytokines mRNA level, including IL-27, IL-27R, TNF-α, and TLR4, in elucidating and discerning the diverse immune system responses. The comprehensive examination of these cytokines' mRNA level assumes considerable importance in understanding the intricate mechanisms underlying kidney rejection processes during this critical period.
BACKGROUNDRenal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection represents a vital, life-preserving endeavor posttransplantation. In this context, the impact of cytokines, notably IL-27, assumes a critical role in managing immune responses aimed at countering rejection. Consequently, this investigation endeavors to explore the precise function of IL-27 and its associated cytokines in the context of kidney transplant rejection.METHODSThe study involved the acquisition of blood samples from a cohort of participants, consisting of 61 individuals who had undergone kidney transplantation (comprising 32 nonrejected patients and 29 rejected patients), and 33 healthy controls. The expression levels of specific genes were examined using SYBR Green Real-time PCR. Additionally, the evaluation encompassed the estimation of the ROC curve, the assessment of the relationship between certain blood factors, and the construction of protein-protein interaction networks for the genes under investigation.RESULTSSignificant statistical differences in gene expression levels were observed between the rejected group and healthy controls, encompassing all the genes examined, except for TLR3 and TLR4 genes. Moreover, the analysis of the Area Under the Curve (AUC) revealed that IL-27, IL-27R, TNF-α, and TLR4 exhibited greater significance in discriminating between the two patient groups. These findings highlight the potential importance of IL-27, IL-27R, TNF-α, and TLR4 as key factors for distinguishing between individuals in the rejected group and those in the healthy control group.CONCLUSIONSIn the context of kidney rejections occurring within the specific timeframe of 2 weeks to 2 months post-transplantation, it is crucial to emphasize the significance of cytokines mRNA level, including IL-27, IL-27R, TNF-α, and TLR4, in elucidating and discerning the diverse immune system responses. The comprehensive examination of these cytokines' mRNA level assumes considerable importance in understanding the intricate mechanisms underlying kidney rejection processes during this critical period.
Author Afshari, Afsoon
Yaghobi, Ramin
Heidari, Mojdeh
Karimi, Aftab
Rahimi, Zahra
Roozbeh, Jamshid
Akbarpoor, Zahra
Author_xml – sequence: 1
  givenname: Aftab
  surname: Karimi
  fullname: Karimi, Aftab
  email: aftabkarimi4955@yahoo.com
  organization: Zarghan branch, Islamic Azad University, Zarghan. aftabkarimi4955@yahoo.com
– sequence: 2
  givenname: Ramin
  surname: Yaghobi
  fullname: Yaghobi, Ramin
  email: rayaviro@yahoo.com
  organization: Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz. rayaviro@yahoo.com
– sequence: 3
  givenname: Jamshid
  surname: Roozbeh
  fullname: Roozbeh, Jamshid
  email: roozbehj@hotmail.com
  organization: Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz. roozbehj@hotmail.com
– sequence: 4
  givenname: Zahra
  surname: Rahimi
  fullname: Rahimi, Zahra
  email: z.rahimi1@yahoo.com
  organization: Zarghan branch, Islamic Azad University, Zarghan. z.rahimi1@yahoo.com
– sequence: 5
  givenname: Afsoon
  surname: Afshari
  fullname: Afshari, Afsoon
  email: afsafshari@yahoo.com
  organization: Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz. afsafshari@yahoo.com
– sequence: 6
  givenname: Zahra
  surname: Akbarpoor
  fullname: Akbarpoor, Zahra
  email: maahsamoon70@gmail.com
  organization: Zarghan branch, Islamic Azad University, Zarghan. maahsamoon70@gmail.com
– sequence: 7
  givenname: Mojdeh
  surname: Heidari
  fullname: Heidari, Mojdeh
  email: mozhde.heidari@gmail.com
  organization: Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz. mozhde.heidari@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38193229$$D View this record in MEDLINE/PubMed
BookMark eNo9kUFv2zAMRoWiQ5t2Pe826LiLE4myLelYFNsaINiAbj0LlEy3zmwrs-wO-fdzkrYXEiA-PoJ4V-y8jz0x9kmKZS6MXGEz4RIEqKWUpZVnbAFgIMul1edsISXkmSpKuGRXKW2FKE2h1AW7VEZaBWAX7PHXOFV7Pj4T7x5-3PKWXqjlsebrTQZ6dawPfIfj8z_c8y62FKaWEm96_qepeppXB-zTrsV-5ANtKYxN7D-yDzW2iW5e-zV7_Pb19919tvn5fX13u8kCKBizPIBRuTbWU6ECYQkieInaVpWXUAoLBBaxCp5sbVQI2vgaRVBUFnWtvbpm6xO3irh1u6HpcNi7iI07DuLw5HAYm9CSs0bPxEBaeJ9bbYwR5NEIFIWm2sqZ9eXE2g3x70RpdF2TArXzZxSn5MBKKEDrEubo6hQNQ0xpoPr9tBTu4MUdvLiDF3f0Mm98foVPvqPqPf8mQv0HW8OJuA
Cites_doi 10.1111/j.1600-6143.2007.01795.x
10.15252/embr.201540337
10.1155/2007/79401
10.1097/TP.0b013e3181fdda0d
10.1093/ndt/gfq589
10.1097/TP.0b013e31825b0c38
10.1111/ajt.14625
10.1038/labinvest.3780364
10.1084/jem.20061440
10.1016/j.coi.2009.07.014
10.18502/ijaai.v17i4.89
10.1016/S0009-9120(00)00188-0
10.1038/s41598-019-48520-7
10.1186/s12882-021-02645-y
10.1007/s00109-007-0164-7
10.1016/S1074-7613(02)00324-2
10.1006/bbrc.1998.8576
10.3109/0886022X.2015.1015425
10.1111/j.1523-1755.2005.00376.x
10.1016/S0962-8924(00)89088-1
10.1016/j.eururo.2004.02.009
10.1097/00007890-199403270-00015
10.1002/eji.200636896
10.1038/ki.2014.285
10.1111/j.1600-6143.2005.00719.x
10.1097/00007890-199304000-00013
10.1016/j.intimp.2008.11.018
10.1172/jci.insight.125489
10.1053/snep.2001.21213
10.1042/CS20100190
10.4049/jimmunol.174.5.2814
10.4049/jimmunol.174.12.7684
10.1096/fj.06-7910com
10.1111/j.1440-1746.2010.06324.x
10.1097/TP.0b013e3181938971
10.1016/j.imbio.2021.152107
10.1093/ndt/gfy206
10.1097/MNH.0000000000000064
10.1093/ndt/gfp782
10.6002/ect.2019.0242
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.4081/aiua.2023.11691
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2282-4197
EndPage 11691
ExternalDocumentID oai_doaj_org_article_987260ce70bb4978880eba80a057ef91
10_4081_aiua_2023_11691
38193229
Genre Journal Article
GroupedDBID 5VS
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c232t-4c2834789be53cea620cb1a79ddb126092e29aadcbe9f83cc78bfa0c3e65ff7b3
IEDL.DBID DOA
ISSN 1124-3562
IngestDate Thu Jul 04 21:04:45 EDT 2024
Fri Jun 28 05:29:19 EDT 2024
Fri Aug 23 01:39:43 EDT 2024
Sun Oct 13 10:28:24 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c232t-4c2834789be53cea620cb1a79ddb126092e29aadcbe9f83cc78bfa0c3e65ff7b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6086-3612
OpenAccessLink https://doaj.org/article/987260ce70bb4978880eba80a057ef91
PMID 38193229
PQID 2912527762
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_987260ce70bb4978880eba80a057ef91
proquest_miscellaneous_2912527762
crossref_primary_10_4081_aiua_2023_11691
pubmed_primary_38193229
PublicationCentury 2000
PublicationDate 2023-12-29
PublicationDateYYYYMMDD 2023-12-29
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-29
  day: 29
PublicationDecade 2020
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Archivio italiano di urologia, andrologia
PublicationTitleAlternate Arch Ital Urol Androl
PublicationYear 2023
Publisher PAGEPress Publications
Publisher_xml – name: PAGEPress Publications
References 106761
106760
106765
106764
106763
106762
106758
106757
106756
106755
106799
106759
106772
106771
106770
106776
106775
106774
106773
106769
106768
106767
106766
106783
106782
106781
106780
106787
106786
106785
106784
106779
106778
106777
106794
106793
106792
106791
106754
106798
106753
106797
106752
106796
106751
106795
106790
106789
106788
References_xml – ident: 106782
  doi: 10.1111/j.1600-6143.2007.01795.x
– ident: 106799
  doi: 10.15252/embr.201540337
– ident: 106770
– ident: 106773
  doi: 10.1155/2007/79401
– ident: 106790
  doi: 10.1097/TP.0b013e3181fdda0d
– ident: 106797
  doi: 10.1093/ndt/gfq589
– ident: 106783
– ident: 106758
  doi: 10.1097/TP.0b013e31825b0c38
– ident: 106762
  doi: 10.1111/ajt.14625
– ident: 106785
  doi: 10.1038/labinvest.3780364
– ident: 106778
  doi: 10.1084/jem.20061440
– ident: 106769
  doi: 10.1016/j.coi.2009.07.014
– ident: 106788
– ident: 106759
  doi: 10.18502/ijaai.v17i4.89
– ident: 106765
  doi: 10.1016/S0009-9120(00)00188-0
– ident: 106779
  doi: 10.1038/s41598-019-48520-7
– ident: 106763
  doi: 10.1186/s12882-021-02645-y
– ident: 106775
  doi: 10.1007/s00109-007-0164-7
– ident: 106755
  doi: 10.1016/S1074-7613(02)00324-2
– ident: 106756
  doi: 10.1006/bbrc.1998.8576
– ident: 106789
  doi: 10.3109/0886022X.2015.1015425
– ident: 106753
  doi: 10.1111/j.1523-1755.2005.00376.x
– ident: 106784
  doi: 10.1016/S0962-8924(00)89088-1
– ident: 106780
– ident: 106777
– ident: 106751
  doi: 10.1016/j.eururo.2004.02.009
– ident: 106766
  doi: 10.1097/00007890-199403270-00015
– ident: 106776
  doi: 10.1002/eji.200636896
– ident: 106772
– ident: 106787
  doi: 10.1038/ki.2014.285
– ident: 106781
  doi: 10.1111/j.1600-6143.2005.00719.x
– ident: 106764
  doi: 10.1097/00007890-199304000-00013
– ident: 106795
  doi: 10.1016/j.intimp.2008.11.018
– ident: 106760
  doi: 10.1172/jci.insight.125489
– ident: 106767
  doi: 10.1053/snep.2001.21213
– ident: 106757
– ident: 106798
  doi: 10.1042/CS20100190
– ident: 106771
  doi: 10.4049/jimmunol.174.5.2814
– ident: 106796
– ident: 106774
  doi: 10.4049/jimmunol.174.12.7684
– ident: 106791
  doi: 10.1096/fj.06-7910com
– ident: 106794
  doi: 10.1111/j.1440-1746.2010.06324.x
– ident: 106786
  doi: 10.1097/TP.0b013e3181938971
– ident: 106792
  doi: 10.1016/j.imbio.2021.152107
– ident: 106761
  doi: 10.1093/ndt/gfy206
– ident: 106752
  doi: 10.1097/MNH.0000000000000064
– ident: 106768
  doi: 10.1093/ndt/gfp782
– ident: 106793
  doi: 10.6002/ect.2019.0242
– ident: 106754
SSID ssj0068533
Score 2.3379226
Snippet Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant rejection...
Background: Renal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant...
BACKGROUNDRenal transplantation stands as the sole remedy for individuals afflicted with end-stage renal diseases, and safeguarding them from transplant...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 11691
SubjectTerms Cytokines
Humans
IL-27
Interleukin-27
Kidney
Kidney Transplantation
Postoperative Complications
Rejection
Toll-Like Receptor 4 - genetics
Transplantation
Tumor Necrosis Factor-alpha
Title Study the mRNA level of IL-27/IL-27R pathway molecules in kidney transplant rejection
URI https://www.ncbi.nlm.nih.gov/pubmed/38193229
https://search.proquest.com/docview/2912527762
https://doaj.org/article/987260ce70bb4978880eba80a057ef91
Volume 95
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUqDqgXBKXAFlq5Ug-9RJu1nTg-AgJRVDigrsTN8jgTafnIomVXFf-eGXsXwaHi0ksOUaw4b5yZN_L4jRA_SvJ4JuqqAFupwgDSP2eCLkaVdbwrF3TFB5wvLuuzsTm_rq5ftfrimrAsD5yBG1JOTJQ7oi0BuBsarTeE0JSBiAbmc-uUw1SrZCr74JqCUCqtp-hVaArxWdTHUPwbhsmC9YaUJm9Ru9GbeJRk-__NNVPMOd0UG0uyKA_zJLfEB-w_ifWL5Xb4thhzFeCTJA4n768uD-UdVwDJaSd__S6UHabrleSmw3_Dk7zPnXDxUU56eTtpe6ShSdv8juCVM7xJZVn9ZzE-PflzfFYs-yQUkfjQvDCROIKxjQOsdMRQqzLCKFjXtjAi8JxC5UJoI6DrGh2jbaALZdRYV11nQe-ItX7a456QoG1Dg9o2KDAKiD5QBqOVBo1QojMD8XOFln_Ichie0ggG1jOwnoH1CdiBOGI0Xx5jHet0g6zrl9b171l3IL6vbOFp3fNmRuhxunj0yhE1U5Z8-UDsZiO9vIqzUHJU7sv_mMK--MgfxSUsyh2ItflsgV-JiMzhW1pzz7Ak1ho
link.rule.ids 315,786,790,870,2115,27955,27956
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Study+the+mRNA+level+of+IL-27%2FIL-27R+pathway+molecules+in+kidney+transplant+rejection&rft.jtitle=Archivio+italiano+di+urologia%2C+andrologia&rft.au=Aftab+Karimi&rft.au=Ramin+Yaghobi&rft.au=Jamshid+Roozbeh&rft.au=Zahra+Rahimi&rft.date=2023-12-29&rft.pub=PAGEPress+Publications&rft.issn=1124-3562&rft.eissn=2282-4197&rft.volume=95&rft.issue=4&rft_id=info:doi/10.4081%2Faiua.2023.11691&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_987260ce70bb4978880eba80a057ef91
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1124-3562&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1124-3562&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1124-3562&client=summon